Genetic biotech company, Camgenium, unveils innovative mobile application aimed at assisting prostate cancer patients.
The HealthiumPro app, a cloud-based software solution, is set to revolutionise prostate cancer care in the UK. This system, designed to address the most common cancer in men in the country, aims to enhance clinical management through the use of technology [1][2].
HealthiumPro is the product of a collaboration between Camgenium and Professor Petre Cristian Ilie. The system is built on the flexible Xenplate platform, which uses a modular, no-code software platform with built-in design tools. This design approach minimises the need for bespoke coding, allowing for a more streamlined and efficient development process [3].
The system assists in automating surgical notes, enabling clinicians to add variables that change from patient to patient. It also offers features such as remote consent forms, pre-surgery information, access to recommended exercises, and the ability to remotely monitor patients' blood pressure and temperature [4].
One of the key features of HealthiumPro is the HealthiumPro Stent Register, which addresses challenges reported by multiple safety bodies in enhancing patient safety and improving the management of ureteric stents. The system also includes a centralised stent database to streamline the logging and tracking of stent insertions [5].
The HealthiumPro system has been built in compliance with ISO 13485, the regulatory standard for medical devices. It has received regulatory approval to be hosted on the NHS private network, HSCN, and is ready for nationwide implementation in other healthcare settings [6].
Dr Ilie stated that HealthiumPro aims to improve patient safety, outcomes, and efficiencies in hospitals. The system has already shown promising results in hospitals where it has been deployed, improving patient care [7].
However, while the potential benefits of HealthiumPro are clear, there is currently a lack of concrete evidence or study results demonstrating improvements in patient outcomes. Further information from clinical studies or healthcare system reports would be needed to assess the actual effectiveness and impact of HealthiumPro on prostate cancer patient outcomes in the UK [8].
It is worth noting that the rate of incidence of prostate cancer is expected to increase by 15% between 2023 and 2040 [9]. This underscores the importance of tools like HealthiumPro in addressing the growing challenge of prostate cancer care.
Camgenium's engineering experts worked closely with Dr Ilie to understand the needs of patients and hospital clinicians. The goal of this collaboration is to improve patient outcomes and allow healthcare professionals to focus more on patients rather than administrative tasks [10].
As the HealthiumPro app continues to be implemented and studied, it will be interesting to see the impact it has on prostate cancer care in the UK. With its focus on patient safety, outcomes, and efficiency, HealthiumPro represents a promising step forward in the fight against prostate cancer.
References: [1] [URL for reference 1] [2] [URL for reference 2] [3] [URL for reference 3] [4] [URL for reference 4] [5] [URL for reference 5] [6] [URL for reference 6] [7] [URL for reference 7] [8] [URL for reference 8] [9] [URL for reference 9] [10] [URL for reference 10]
- The HealthiumPro app, a medical device, is built on the Xenplate platform and utilizes health tech to streamline patient care in prostate cancer management, especially in the UK where it's the most common cancer in men.
- The HealthiumPro system, designed with patient safety and efficiency in mind, includes features like automating surgical notes, remote consent forms, pre-surgery information, access to exercise recommendations, and remote patient monitoring.
- HealthiumPro's development complies with ISO 13485, the regulatory standard for medical devices, and has received approval to be hosted on the NHS private network, HSCN, ready for nationwide implementation across various healthcare settings.
- The goal of HealthiumPro, a cloud-based software solution, is to improve patient outcomes by allowing healthcare professionals to focus more on patients rather than administrative tasks, potentially leading to advancements in health-and-wellness therapies and treatments for prostate cancer patients.
